SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.
about
SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@en
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@nl
type
label
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@en
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@nl
prefLabel
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@en
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@nl
P2093
P2860
P356
P1433
P1476
SOX9 is a driver of aggressive ...... ial to mesenchymal transition.
@en
P2093
Amy Capper
Eleanor Knight
Johann de Bono
P2860
P304
P356
10.18632/ONCOTARGET.24123
P407
P577
2018-01-10T00:00:00Z